GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Link Pharma Chem Ltd

Link Pharma Chem Q2 FY27 Loss of Rs. 22.31 Lakhs on Revenue of Rs. 533.13 Lakhs

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 03 Nov 2026, 12:46 PM IST  ·  BSE ID: 35ea269b-6896-4c9c-a686-9d854bb03827
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's latest financial report shows it made Rs. 533.13 Lakhs in sales but lost Rs. 22.31 Lakhs this past quarter.
🤖 AI Summary
  • Board of Directors approved unaudited financial results for Q2 FY27 on November 03, 2026.
  • Company reported a net loss of Rs. 22.31 Lakhs for the quarter ended September 30, 2026.
  • Revenue from operations for Q2 FY27 was Rs. 533.13 Lakhs.
  • Half-yearly net profit stood at Rs. 9.52 Lakhs for the period April 01, 2026 to September 30, 2026.
  • Half-yearly revenue from operations was Rs. 1,409.97 Lakhs.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
533.13 Rs. In Lakhs
Revenue from operations (Q2 FY26)
629.32 Rs. In Lakhs
Net (Loss)/Profit for the period (Q2 FY27)
(22.31) Rs. In Lakhs
Net (Loss)/Profit for the period (Q2 FY26)
1.56 Rs. In Lakhs
Revenue from operations (Half-year ended Sep 30, 2026)
1,409.97 Rs. In Lakhs
Net (Loss)/Profit for the period (Half-year ended Sep 30, 2026)
9.52 Rs. In Lakhs
🏢 How This Affects the Company
📈
Business Impact
Q2 FY27 revenue from operations declined by Rs. 96.19 Lakhs compared to Q2 FY26. Half-yearly revenue also slightly decreased by Rs. 0.83 Lakhs compared to the prior half-year period.
💰
Financial Impact
The company reported a net loss of Rs. 22.31 Lakhs in Q2 FY27, a decline from a net profit of Rs. 1.56 Lakhs in Q2 FY26. Total expenses for the quarter remained substantial at Rs. 553.63 Lakhs.
⚠️
Risk Impact
Sustained quarterly losses could strain working capital and cash reserves. Current liabilities exceeded current assets by Rs. 740.06 Lakhs as of September 30, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the reported financial performance, specifically the Q2 FY27 net loss of Rs. 22.31 Lakhs and the half-yearly net profit of Rs. 9.52 Lakhs.
🔍
Management Signal
The Board's approval and disclosure of these results demonstrate adherence to regulatory requirements for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for sustained profitability and revenue growth.
Review of raw material costs — monitor cost of materials consumed in upcoming quarters.
Cash flow from operations — observe improvements in operating cash generation.
MEDIUM RISK The company reported a quarterly net loss, and revenue from operations declined compared to the prior year's quarter.
💡 Investor Takeaway
Link Pharma Chem reported a Q2 FY27 net loss of Rs. 22.31 Lakhs on revenue from operations of Rs. 533.13 Lakhs. This contrasts with a net profit of Rs. 1.56 Lakhs on revenue of Rs. 629.32 Lakhs in Q2 FY26. Half-yearly net profit stood at Rs. 9.52 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Half-yearly revenue from operations remained stable at Rs. 1,409.97 Lakhs, compared to Rs. 1,410.80 Lakhs in the prior half-year.
  • Other equity increased to Rs. 846.30 Lakhs as of September 30, 2026, from Rs. 834.86 Lakhs on March 31, 2026.

⚠️ Concerns

  • Q2 FY27 revenue from operations decreased to Rs. 533.13 Lakhs from Rs. 629.32 Lakhs in Q2 FY26.
  • The company recorded a net loss of Rs. 22.31 Lakhs in Q2 FY27, compared to a net profit of Rs. 1.56 Lakhs in Q2 FY26.
📅 Company Track Record
In Q1 FY27 (quarter ended June 30, 2026), Link Pharma Chem reported revenue of Rs. 876.84 million and profit before tax of Rs. 38.87 million. The current Q2 FY27 results indicate a decline from the preceding quarter's performance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Link Pharma Chem's net profit/loss in Q2 FY27?
Link Pharma Chem reported a net loss of Rs. 22.31 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was Link Pharma Chem's revenue from operations in Q2 FY27?
Revenue from operations for Link Pharma Chem in Q2 FY27 was Rs. 533.13 Lakhs.
How does Q2 FY27 revenue compare to Q2 FY26 for Link Pharma Chem?
Link Pharma Chem's revenue from operations in Q2 FY27 was Rs. 533.13 Lakhs, which was lower than Rs. 629.32 Lakhs reported in Q2 FY26.
What was Link Pharma Chem's half-yearly net profit for the period ended September 30, 2026?
For the half-year ended September 30, 2026, Link Pharma Chem reported a net profit of Rs. 9.52 Lakhs.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.